CARGO Therapeutics Statistics

Total Valuation

CRGX has a market cap or net worth of $215.70 million. The enterprise value is -$36.28 million.

Market Cap	215.70M
Enterprise Value	-36.28M

Important Dates

The last earnings date was Wednesday, August 6, 2025, after market close.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CRGX has 48.36 million shares outstanding. The number of shares has increased by 79.29% in one year.

Current Share Class	48.36M
Shares Outstanding	48.36M
Shares Change (YoY)	+79.29%
Shares Change (QoQ)	+0.59%
Owned by Insiders (%)	0.18%
Owned by Institutions (%)	42.64%
Float	27.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.87
P/TBV Ratio	0.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.37, with a Debt / Equity ratio of 0.00.

Current Ratio	12.37
Quick Ratio	12.12
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -65.83% and return on invested capital (ROIC) is -27.61%.

Return on Equity (ROE)	-65.83%
Return on Assets (ROA)	-25.91%
Return on Invested Capital (ROIC)	-27.61%
Return on Capital Employed (ROCE)	-65.29%
Revenue Per Employee	n/a
Profits Per Employee	-$1.33M
Employee Count	167
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-69.24%
50-Day Moving Average	4.46
200-Day Moving Average	8.15
Relative Strength Index (RSI)	48.24
Average Volume (20 Days)	1,802,371

Short Selling Information

The latest short interest is 3.04 million, so 6.28% of the outstanding shares have been sold short.

Short Interest	3.04M
Short Previous Month	3.46M
Short % of Shares Out	6.28%
Short % of Float	11.25%
Short Ratio (days to cover)	1.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-155.19M
Pretax Income	n/a
Net Income	-221.78M
EBITDA	-152.99M
EBIT	-155.19M
Earnings Per Share (EPS)	-$4.63

Full Income Statement

Balance Sheet

The company has $252.57 million in cash and $578,000 in debt, giving a net cash position of $251.99 million or $5.21 per share.

Cash & Cash Equivalents	252.57M
Total Debt	578,000
Net Cash	251.99M
Net Cash Per Share	$5.21
Equity (Book Value)	237.70M
Book Value Per Share	5.11
Working Capital	237.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$189.59 million and capital expenditures -$2.18 million, giving a free cash flow of -$191.77 million.

Operating Cash Flow	-189.59M
Capital Expenditures	-2.18M
Free Cash Flow	-191.77M
FCF Per Share	-$3.97

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRGX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-79.29%
Shareholder Yield	-79.29%
Earnings Yield	-102.82%
FCF Yield	-88.90%

Analyst Forecast

The average price target for CRGX is $5.33, which is 19.51% higher than the current price. The consensus rating is "Hold".

Price Target	$5.33
Price Target Difference	19.51%
Analyst Consensus	Hold
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-7.75%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1